ReviewJournal of biomedical science2016

Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors.

Bin-Chi Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.